UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 10.

Matter-Walstra, K W; Achermann, R; Rapold, R; Klingbiel, D; Bordoni, A; Dehler, S; Konzelmann, I; Mousavi, M; Clough-Gorr, K M; Szucs, T; Schwenkglenks, M; Pestalozzi, B C (2017). Days spent in acute care hospitals at the end of life of cancer patients in four Swiss cantons: a retrospective database study (SAKK 89/09). European Journal of Cancer Care, 26(4):e12453.

Joerger, M; Matter-Walstra, K; Früh, M; Kühnel, U; Szucs, T; Pestalozzi, B; Schwenkglenks, M (2011). Addition of cetuximab to first-line chemotherapy in patients with advanced non-small-cell lung cancer: a cost-utility analysis. Annals of Oncology, 22(3):567-574.

Farshad, M; Gerber, C; Szucs, T; Meyer, D C (2011). Determining utility values in patients with anterior cruciate ligament tears using clinical scoring systems. BMC Health Services Research, 11:182.

Monto, A; Fedson, D; Szucs, T; Nichol, K (2009). SIP 1: Increasing the overall epidemic vaccination coverage. Epidemic vaccination coverage: it's a long way to Tipperary. Vaccine, 27(45):6370-6373.

Elbasha, E E; Szucs, T; Chaudhary, M A; Kumar, R N; Roediger, A; Cook, J R; Opravil, M (2009). Cost-effectiveness of raltegravir in antiretroviral treatment-experienced HIV-1-infected patients in Switzerland. HIV Clinical Trials, 10(4):233-253.

Ruf, B R; Szucs, T (2009). Reducing the burden of influenza-associated complications with antiviral therapy. Infection, 37(3):186-196.

Romanens, M; Ackermann, F; Abay, M; Szucs, T; Schwenkglenks, M (2009). Agreement of Swiss-adapted international and European guidelines for the assessment of global vascular risk and for lipid lowering interventions. Cardiovascular Drugs and Therapy, 23(3):249-254.

Neeser, K; Szucs, T; Bulliard, J L; Bachmann, G; Schramm, W (2007). Cost-effectiveness analysis of a quality-controlled mammography screening program from the Swiss statutory health-care perspective: quantitative assessment of the most influential factors. Value in Health, 10(1):42-53.

Beglinger, C; Thalmann, C; Szucs, T; Michetti, P (2006). Long-term treatment of patients with symptomatic gastroesophageal reflux disease comparing costs and efficacy over 6 months of treatment with Nexium On-Demand Treatment or Nexium continuous treatment. An open, randomised multi-center study. Praxis, 95(13):483-487.

Kubik-Huch, R A; Rexroth, M; Porst, R; Dürselen, L; Otto, R; Szucs, T (2005). Wie zufrieden sind die klinischen Partner mit der Arbeit eines radiologischen Instituts? Entwicklung und Testung eines Fragebogens. RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin, 177(3):429-434.

This list was generated on Tue Jul 25 05:08:13 2017 CEST.